Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. OCUL
OCUL logo

OCUL News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OCUL News

Wall Street Analysts Adjust GE Stock Ratings

Mar 03 2026Benzinga

OCUL Stock 52-Week High and Low Analysis

Mar 02 2026NASDAQ.COM

Ocular Therapeutix Shares Drop Amid Inflation Concerns

Feb 28 2026Yahoo Finance

Analysis of Potential and Risks in Small-Cap Stocks

Feb 27 2026Yahoo Finance

iShares Expanded Tech-Software ETF Underperforms

Feb 23 2026NASDAQ.COM

Ocular Therapeutix to Present AXPAXLI Trial Results at Macula Society Meeting

Feb 23 2026NASDAQ.COM

Investigation into Ocular Therapeutix Investor Claims

Feb 18 2026Globenewswire

U.S. Stocks Mostly Lower, Nasdaq Drops Over 50 Points

Feb 17 2026Benzinga

OCUL Events

02/17 16:40
Major U.S. Averages End Broadly Higher, Nasdaq Up 0.14%
The major averages ended broadly higher following the long weekend, rising from a mixed midday after the U.S. and Iran reportedly made "progress" in nuclear talks in Geneva. Earlier weakness reflected renewed concerns about artificial intelligence-related disruption after last week's weakness in tech and software stocks.Looking to commodities, gold was sharply lower, reversing some of last week's gains, while oil also fell.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Warner Bros. Discoverywillwith Paramount Skydance, though Netflixretains its matching rightsDanaherMasimofor $180 per share in cash, or a total consideration of $9.9BActivist investor Elliott has built a more than 10% stake in Norwegian Cruise Line,Meanwhile, Jana Partners has built a stake in Fiserv,Medtronicreportedand reiterated its FY26 earnings guidance2. WALL STREET CALLS:Dollar Treeto Buy at Rothschild & Co RedburnRothschildDollar Generalto Sell on valuationShopifyto Buy at Truist amid market dislocationRivianto Underperform at DA Davidson on R2 ramp risksBitGocoverage wasaround the Street with mainly Buy and equivalent ratings3. AROUND THE WEB:Appleis fast-tracking development of its Glasses, Pendant, and Camera Airpod products for the AI era, Bloomberg reportsGemini'sCOO Marshall Beard, CFO Dan Chen, and chief legal officer Tyler Meade have all left the company, Bloomberg saysVolkswagenintends to cut costs by 20% across its brands by the end of 2028, Reuters reportsEli Lillyintends to turn India into a hub for its global supply chain, Reuters saysBayeris preparing a $10.5B settlement plan to address ongoing and future cancer claims tied to Roundup, Bloomberg says4. MOVERS:Compass Pathwaysincreases in New York after announcing its Phase 3 COMP006 trialZIM Integratedgains in New York after announcing itby Hapag-Lloydfor $35 per share in casheTorohigher in New York afterand approving a $100M increase to its share repurchase programOcular Therapeutixfalls after reporting results from theNeoGenomicslower afterand providing guidance for FY265. EARNINGS/GUIDANCE:Somnigroupand provided guidance for FY26, with CEO Scott Thompson commenting, "These results mark a continuation of the strength we displayed throughout the year"Itronand provided guidance for Q1 and FY26LGI Homes, with EPS beating consensusValmont, with EPS and revenue missing consensusLeidos, with CEO Tom Bell commenting, "Our performance this quarter and throughout the year underscores the incredible resilience of our team"INDEXES:The Dow rose 32.26, or 0.065%, to 49,533.19, the Nasdaq gained 31.72, or 0.14%, to 22,578.39, and the S&P 500 advanced 7.05, or 0.10%, to 6,843.22.

OCUL Monitor News

Ocular Therapeutix shares rise despite broader market decline

Mar 02 2026

Ocular Therapeutix Faces Stock Decline Amid Market Weakness

Feb 17 2026

Ocular Therapeutix Stock Surges After Rejecting Sanofi's Bid

Jan 15 2026

Ocular Therapeutix Inc Surges After NDA Submission Announcement

Dec 08 2025

OCUL Earnings Analysis

Ocular Therapeutix Inc Reports Third Quarter 2024 Financial Results
1 years ago

People Also Watch